Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mechanisms of Exercise Intolerance in Cystic Fibrosis: Role of PDE5 Inhibition

NCT04039087 is registered in ClinicalTrials.gov with National Jewish Health as lead sponsor.

NCT NCT04039087
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04039087 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mechanisms of Exercise Intolerance in Cystic Fibrosis: Role of PDE5 Inhibition
Lead sponsor
National Jewish Health
Phase
Phase 2/3
Overall status
Completed
Start date
September 5, 2019
Completion date
June 30, 2024
Enrollment
31 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis